- 日
- 関
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2018/09/30 20:37:39」(JST)
[Wiki en表示]
Not to be confused with Dihydrotestosterone.
Dihydrotachysterol
|
|
Clinical data |
---|
AHFS/Drugs.com |
Micromedex Detailed Consumer Information |
---|
MedlinePlus |
a682335 |
---|
ATC code |
|
---|
Identifiers |
---|
IUPAC name
- (1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
|
CAS Number |
|
---|
PubChem CID |
|
---|
DrugBank |
|
---|
ChemSpider |
|
---|
UNII |
|
---|
KEGG |
|
---|
ChEBI |
|
---|
ECHA InfoCard |
100.000.611 |
---|
Chemical and physical data |
---|
Formula |
C28H46O |
---|
Molar mass |
398.664 g/mol |
---|
3D model (JSmol) |
|
---|
SMILES
O[C@@H]3C/C(=C\C=C1/CCC[C@]2([C@H]1CC[C@@H]2[C@@H](/C=C/[C@H](C)C(C)C)C)C)[C@@H](C)CC3
|
InChI
InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1 Y Key:ILYCWAKSDCYMBB-OPCMSESCSA-N Y
|
(verify) |
---|
Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.[1]
References
- ^ R. Gagnon; G. W. Ogden; G. Just; M. Kaye (1974). "Comparison of Dihydrotachysterol and 5,6-trans Vitamin D3 on Intestinal Calcium Absorption in Patients with Chronic Renal Failure". Canadian Journal of Physiology and Pharmacology. 52 (2): 272–274. doi:10.1139/y74-037. PMID 4365509.
Cholestanes, membrane lipids: sterols |
---|
- Adosterol
- Cholecalciferol/Ergocalciferols
- Cholesterol
- Dihydrotachysterol
- Fusidic acid
- Lanosterol
- Phytosterols
|
Vitamins (A11) |
---|
Fat soluble | A |
- α-Carotene
- β-Carotene
- Retinol#
- Tretinoin
|
---|
D |
- D2
- Ergosterol
- Ergocalciferol#
- D3
- 7-Dehydrocholesterol
- Previtamin D3
- Cholecalciferol#
- 25-hydroxycholecalciferol
- Calcitriol (1,25-dihydroxycholecalciferol)
- Calcitroic acid
- D4
- D5
- D analogues
- Alfacalcidol
- Dihydrotachysterol
- Calcipotriol
- Tacalcitol
- Paricalcitol
|
---|
E |
- Tocopherol
- Tocotrienol
- Tocofersolan
|
---|
K |
- Naphthoquinone
- Phylloquinone (K1)
- Menaquinones (K2)
- Menadione (K3)‡
- Menadiol (K4)
|
---|
|
---|
Water soluble | B |
- B1
- B1 analogues
- Acefurtiamine
- Allithiamine
- Fursultiamine
- Octotiamine
- Prosultiamine
- Sulbutiamine
- B2
- B3
- B5
- Pantothenic acid
- Dexpanthenol
- Pantethine
- B6
- Pyridoxine#, Pyridoxal phosphate
- Pyridoxamine
- Pyritinol
- B7
- B9
- Folic acid
- Dihydrofolic acid
- Folinic acid
- Levomefolic acid
- B12
- Adenosylcobalamin
- Cyanocobalamin
- Hydroxocobalamin
- Methylcobalamin
- Choline
|
---|
C |
- Ascorbic acid#
- Dehydroascorbic acid
|
---|
|
---|
Combinations | |
---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
Vitamin D receptor modulators |
---|
VDR |
- Agonists: 7-Dehydrocholesterol
- 22-Oxacalcitriol
- 25-Hydroxyergocalciferol
- Alfacalcidol
- Calcifediol
- Calciferol
- Calcipotriol
- Calcitriol
- Cholecalciferol (vitamin D3)
- Dihydrotachysterol
- Doxercalciferol
- EB-1089
- Eldecalcitol
- Ercalcidiol
- Ercalcitriol
- Ergocalciferol (vitamin D2)
- Lithocholic acid
- Paricalcitol
- Tacalcitol
|
---|
- See also
- Receptor/signaling modulators
- Nuclear receptor modulators
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Surgery of benign thyroid disease by ENT/head and neck surgeons and general surgeons: 233 cases of vocal fold paralysis in 3509 patients.
- Kohnen B, Schürmeyer C, Schürmeyer TH, Kress P.
- European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2018 Sep;275(9)2397-2402.
- Thyroid surgery is mainly performed by general surgeons (GS). The aim of this study is to evaluate the safety and efficiency of thyroid surgery by ENT/head and neck surgeons (ENT), especially regarding the incidence of vocal fold palsy (VFP). We retrospectively analysed 3509 patients (69.0% female)
- PMID 30074074
- [Severe hypercalcemia of unusual cause, looking for the culprit: Case report and review of the literature].
- Jalbert M, Mignot A, Gauchez AS, Dobrokhotov AC, Fourcade J.
- Nephrologie & therapeutique. 2018 Jun;14(4)231-236.
- Hypercalcemia is not a rare event and can lead to severe consequences. Its main etiologies are primary hyperparathyroidism and neoplasic conditions. The iatrogenic etiology by vitamin D intoxication is more rarely found. A 76-year-old finish woman comes to the emergency room for chest pain. Her medi
- PMID 29709532
- Erythrocyte Senescence in a Model of Rat Displaying Hutchinson-Gilford Progeria Syndrome.
- Chaudhary MK, Rizvi SI.
- Analytical cellular pathology (Amsterdam). 2018 ;2018()5028925.
- Increased oxidative stress is a major cause of aging and age-related diseases. Erythrocytes serve as good model for aging studies. Dihydrotachysterol is known to induce premature aging feature in rats mimicking Hutchinson-Gilford progeria syndrome. In the present study, attempts have been made to ex
- PMID 30003010
Japanese Journal
- 原発性副甲状腺機能こう進症に慢性すい炎を合併し20年の経過後,腎不全にて死亡した1剖検症例
- <原著>慢性透析症例の腎性骨異栄養症に対する活性型vitamin D_3 analogue剤長期投与の効果
Related Links
- Physician reviewed dihydrotachysterol patient information - includes dihydrotachysterol description, dosage and directions. ... Dihydrotachysterol dosing information Usual Adult Dose for Hypocalcemia: Initial dose: 0.25 to 0.8 mg ...
- Lists the various brand names available for medicines containing dihydrotachysterol. Find information on dihydrotachysterol use, treatment, drug class and molecular formula. ... Disclaimer: The indications, uses and warnings for ...
Related Pictures